Increased paclitaxel resistance in recurrent epithelial ovarian cancer: analysis of metachronous tumors

Author： Matsuo Koji   Im Dwight   Rosenshein Neil  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.15, Iss.3, 2010-06, pp. : 325-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Results of Reinduction Therapy with Paclitaxel and Carboplatin in Recurrent Epithelial Ovarian Cancer

By Gronlund B.   Hogdall C.   Hansen H.H.   Engelholm S.A.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 128-134

Elsevier

Access to resources Recommend Favorite

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

By Goldberg J.M.   Piver M.S.   Hempling R.E.   Recio F.O.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 312-317

Academic Press

Access to resources Recommend Favorite

Splenectomy in Recurrent Epithelial Ovarian Cancer

By Gemignani M.L.   Chi D.S.   Gurin C.C.   Curtin J.P.   Barakat R.R.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 407-410

Elsevier

Access to resources Recommend Favorite

Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer

By Eltabbakh G.H.   Piver M.S.   Hempling R.E.   Recio F.O.   Lele S.B.   Marchetti D.L.   Baker T.R.   Blumenson L.E.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and Tau expression

By                

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1736-1744

Spandidos Publications

Access to resources Recommend Favorite